D68.32 Hemorrhagic disorder due to extrinsic circulating anticoagulants
Instructional Notes:
-
D68.32
Description: Hemorrhagic disorder due to extrinsic circulating anticoagulants
Use Additional Code:
- code for adverse effect, if applicable, to identify drug (T45.515, T45.525)
Inclusion Term:
- Drug-induced hemorrhagic disorder
- Hemorrhagic disorder due to increase in anti-IIa
- Hemorrhagic disorder due to increase in anti-Xa
- Hyperheparinemia
↓
-
D68.3
Description: Hemorrhagic disorder due to circulating anticoagulants
↓
-
D68
Description: Other coagulation defects
Exclude1:
- abnormal coagulation profile NOS (R79.1)
Exclude2:
- coagulation defects complicating abortion or ectopic or molar pregnancy (O00-O07, O08.1)
- coagulation defects complicating pregnancy, childbirth and the puerperium (O45.0, O46.0, O67.0, O72.3)
↓
-
D65-D69
Description: Coagulation defects, purpura and other hemorrhagic conditions (D65-D69)
↓
-
D50-D89
Description: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Exclude2:
- autoimmune disease (systemic) NOS (M35.9)
- certain conditions originating in the perinatal period (P00-P96)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- human immunodeficiency virus [HIV] disease (B20)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)